Form 4: Electromed Director Granted 3,000 Restricted Shares

Electromed, Inc. Director Joseph L. Galatowitsch was granted 3,000 shares of restricted common stock, vesting on June 1, 2026.

Summary

• Joseph L. Galatowitsch, a Director of Electromed, Inc. (ELMD), acquired 3,000 shares of common stock.
• The acquisition occurred on December 1, 2025, at a price of $0 per share, indicating a grant.
• These shares are restricted stock and are scheduled to vest on June 1, 2026, unless earlier accelerated or terminated.
• Following this transaction, Mr. Galatowitsch beneficially owns 15,000 shares of Electromed, Inc. common stock directly.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: A director receiving a stock grant is generally a positive sign of alignment and commitment, though it's a routine compensation event rather than a major strategic announcement.

Positives

• Director Joseph L. Galatowitsch received a grant of 3,000 restricted shares, aligning his interests with shareholders.
• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-planned, non-discretionary acquisition.

Risks

• The restricted stock grant is subject to vesting conditions, meaning the shares are not fully owned until June 1, 2026, and could be forfeited if terms are not met.

Future Outlook

The grant of restricted stock with a future vesting date of June 1, 2026, indicates a long-term incentive for the director, aligning their future performance with shareholder value.

Industry Context

Insider stock grants are a common practice in publicly traded companies, particularly for directors, as a form of compensation and to align their interests with long-term company performance and shareholder value. This is standard practice in the medical device industry where Electromed operates.

Comparison to Industry Standards

• Granting restricted stock to directors is a standard compensation practice across various industries, including medical devices, to incentivize long-term commitment and performance.
• The $0 acquisition price is typical for stock grants as part of an equity compensation plan, rather than an open market purchase.
• The use of a Rule 10b5-1(c) plan is a common corporate governance practice to demonstrate that insider transactions are pre-planned and not based on material non-public information.

Corporate Governance

Related Party Transactions

• Grant of 3,000 restricted shares to Joseph L. Galatowitsch, a Director of Electromed, Inc., as part of his compensation.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with long-term shareholder value.
• Employees: May signal stability and commitment from leadership.

Next Steps

• The restricted shares are scheduled to vest on June 1, 2026.

Key Dates

Recommendation

This Form 4 reports a routine insider stock grant to a director as part of their compensation, which is a standard practice to align interests. It does not contain information that would fundamentally alter the investment thesis for Electromed, Inc., warranting a change from a 'hold' position based solely on this filing.

Keywords

Electromed, ELMD, Joseph L. Galatowitsch, Director, Restricted Stock, Stock Grant, Insider Trading, Form 4, Beneficial Ownership, Corporate Governance